Therapeutic Education by Telemedicine in Chronic Heart Failure
NCT ID: NCT00878202
Last Updated: 2013-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
100 participants
INTERVENTIONAL
2009-03-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heart Failure Educational and Follow up Platform
NCT02110433
Optimization of the Ambulatory Monitoring for Patients With Heart Failure by Tele-cardiology
NCT02068118
Web-based Training and Telephone Follow-up of Patients With Heart Failure: Randomized Controlled Trial
NCT04210167
Therapeutic Education Strategy for Patients With Acute Heart Failure
NCT03035123
Platform Therapeutic Education in Heart Failure and Coronary Disease
NCT01869452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Optimal medical treatment of Heart failure and therapeutic education
No interventions assigned to this group
Telemedicine
Optimal medical treatment of heart failure disease and therapeutic education
SCAD information system
Clinical follow-up and continuation of therapeutic education by telemedicine during 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SCAD information system
Clinical follow-up and continuation of therapeutic education by telemedicine during 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Left ventricle systolic Dysfunction with ejection fraction \< 45 %, documented in the previous 6 months
* And at least one of the following criteria:
BNP before discharge from hospital \> 350 pg/ml / EF \< 35 % / Hospitalization for acute heart failure informed in the previous 6 months
Exclusion Criteria
* Planned cardiac surgery or coronary revascularization
* Hospitalization for ST-elevation acute coronary syndrome
* Depressive syndrome with score \> 20 at geriatric depression scale
* Therapeutic education impossible
* Technical problems with the device
* Limited autonomy for device use
* Patient not living in Basse-Normandie
* Ongoing participation in another clinical trial
65 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rémi Sabatier, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Caen
Annette Belin, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Caen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alençon-Mamers Hospital
Alençon, , France
Caen University Hospital
Caen, , France
Cherbourg Hospital
Cherbourg, , France
Flers Hospital
Flers, , France
Lisieux Hospital
Lisieux, , France
Saint-Lo Hospital
Saint-Lô, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B80909-60
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.